Level and determinants of pharmacovigilance programme awareness in Nigeria: A multilevel analysis
暂无分享,去创建一个
S. Adebayo | J. Akinyemi | E. Bamgboye | A. Fagbamigbe | Issa Kawu | O. Yusuf | M. Akpa | O. Ezire | O. D. Alo | Perpetual Agbi
[1] J. Robertson,et al. Low awareness of adverse drug reaction reporting systems: a consumer survey , 2013, The Medical journal of Australia.
[2] A. Avery,et al. Survey to assess public awareness of patient reporting of adverse drug reactions in Great Britain , 2012, Journal of clinical pharmacy and therapeutics.
[3] O. Ogunleye,et al. The knowledge, perceptions and practice of pharmacovigilance amongst community pharmacists in Lagos state, south west Nigeria , 2011, Pharmacoepidemiology and drug safety.
[4] O. Iribhogbe,et al. Extent of pharmacovigilance among resident doctors in Edo and Lagos states of Nigeria , 2010, Pharmacoepidemiology and drug safety.
[5] Naifeng Liu,et al. A hospital‐based survey of healthcare professionals in the awareness of pharmacovigilance , 2009, Pharmacoepidemiology and drug safety.
[6] Z. Aziz,et al. Reporting of adverse drug reactions: predictors of under‐reporting in Malaysia , 2007, Pharmacoepidemiology and drug safety.
[7] S. Bello,et al. Knowledge and attitudes of physicians relating to reporting of adverse drug reactions in Sokoto, north-western Nigeria. , 2011, Annals of African medicine.
[8] H. Galadima,et al. Federal Republic of Nigeria , 2009 .
[9] Sophia Rabe-Hesketh,et al. Multilevel and longitudinal modeling using Stata. 2nd edition , 2008 .